Assertio Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapeutics to address unmet medical needs in various therapeutic areas
With a commitment to improving patient outcomes, the company specializes in delivering treatments for diseases such as pain and other central nervous system disorders. Assertio employs a range of scientific approaches, including the advancement of specialized drug formulations and targeted delivery systems, in order to enhance efficacy and patient adherence to treatment. Through its innovative product offerings and robust pipeline, Assertio aims to provide effective solutions that empower patients to lead healthier lives.
CAMBRIDGE, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Sravan K. Emany as chief financial officer (CFO), effective December 19, 2024. Mr. Emany brings to Beam a breadth of global operational, commercial and financial experience with multinational public corporations and financial institutions. He most recently served as CFO and chief operating officer at Ironwood Pharmaceuticals, Inc.
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Assertio Holdings, Inc. (NASDAQASRT) on behalf of long-term stockholders following a class action complaint that was filed against Assertio on January 5, 2024 with a Class Period from March 9, 2023 to November 8, 2023. Our investigation concerns whether the board of directors of Assertio have breached their fiduciary duties to the company.
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Assertio Holdings, Inc. (NASDAQASRT) on behalf of long-term stockholders following a class action complaint that was filed against Assertio on January 5, 2024 with a Class Period from March 9, 2023 to November 8, 2023. Our investigation concerns whether the board of directors of Assertio have breached their fiduciary duties to the company.
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQBLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
The Law Offices of Frank R. Cruz reminds investors of the upcoming March 5, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQASRT) securities between March 9, 2023 and November 8, 2023, inclusive (the “Class Period”).
PHILADELPHIA, March 04, 2024 (GLOBE NEWSWIRE) -- Attention Assertio Holdings, Inc. (“Assertio”) (NASDAQASRT) Investors. A securities fraud class action lawsuit has been filed against Assertio on behalf of purchasers of Assertio’s securities between March 9, 2023 and November 8, 2023, inclusive (the “Class Period”).
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQASRT) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Assertio securities between March 9, 2023 and November 8, 2023, both dates inclusive (the “Class Period”). Investors have until March 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQASRT) and reminds investors of the March 5, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Maison Solutions Inc. (NASDAQMSS), Assertio Holdings, Inc. NASDAQ: ASRTNASDAQASRT)(NASDAQ: DADANASDAQDADA, and Cummins Inc. (NYSE: CMINYSE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Assertio Holdings, Inc. (“Assertio”) (NASDAQASRT). The action charges Assertio with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Assertio’ s materially misleading statements and omissions to the public, Assertio’s investors have suffered significant losses.
NEW YORK, Feb. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Maison Solutions Inc. (NASDAQMSS), Assertio Holdings, Inc. NASDAQ: ASRTNASDAQASRT)(NASDAQ: DADANASDAQDADA, and Cummins Inc. (NYSE: CMINYSE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/ASRT.
NEW YORK, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of VNET Group, Inc. (NASDAQVNET), Assertio Holdings, Inc. NASDAQ: ASRTNASDAQASRT)(NYSE: CMINYSECMI, and Brooge Energy Limited (NASDAQ: BROGNASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
